Publications by authors named "A M Calderon-de la Barca"
Scuole che promuovono salute (Sps) is a model promoted by the World Health Organization and recognized at the European and national levels for promoting health and well-being at school. Pause Attive is an effective and evidence-based intervention to promote physical activity and reduce sedentary behaviour of children in the school setting. In the 2023-2024 school year, 348 schools joined the "Rete Lazio Sps" of which 99 joined the intervention Pause Attive for a total of 1.
View Article and Find Full Text PDFArticle Synopsis
- Dengue virus (DENV) is spreading to new temperate regions, including Europe, due to global trade and climate change, resulting in local outbreaks even among non-travelers.
- A study in the Latium Region from August to November 2023 investigated local DENV infections caused by serotypes 1, 2, and 3, using advanced sequencing techniques for genetic analysis.
- The findings revealed that the predominant DENV-1 strain, which originated from South America, had led to 42 local infections in Rome, indicating adaptation of the virus to human hosts and changes in how it interacts with antibodies and cell receptors.
Reconfiguration of chemical sensors, intended as the capacity of the sensor to adapt to novel operational scenarios, e.g., new target analytes, is potentially game changing and would enable rapid and cost-effective reaction to dynamic changes occurring at healthcare, environmental, and industrial levels.
View Article and Find Full Text PDFArticle Synopsis
- * The scaffolds were made using a process called in situ biomineralization and freeze-drying, which enhanced their mechanical properties and distribution of nanohydroxyapatite.
- * Cytocompatibility testing showed that the 10% nanohydroxyapatite layers supported cell growth similarly to pure chitosan, with no harmful effects detected at up to 20%, making this design a potential solution for mimicking complex tissues like osteochondral tissue.
Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort study.
EClinicalMedicine
February 2024
Background: Pre-exposure vaccination with MVA-BN has been widely used against mpox to contain the 2022 outbreak. Many countries have defined prioritized strategies, administering a single dose to those historically vaccinated for smallpox, to achieve quickly adequate coverage in front of low supplies. Using epidemiological models, real-life effectiveness was estimated at approximately 36%-86%, but no clinical trials were performed.
View Article and Find Full Text PDF